{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:20:40Z","timestamp":1759191640841,"version":"3.44.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["IITP-2024-RS-2024-00438239"],"award-info":[{"award-number":["IITP-2024-RS-2024-00438239"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18723-2","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:41:41Z","timestamp":1759171301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disproportionality analysis of infection associated with antidiabetic drug use patterns"],"prefix":"10.1038","volume":"15","author":[{"given":"Tae Hyeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeongmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seoyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyesu","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunjee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaehyeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Youl","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Hajek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Branda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Jin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaewon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Keon","family":"Yon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"18723_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong, K. L. et al. Global, regional, and National burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet 402, 203\u2013234. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6 (2023).","journal-title":"Lancet"},{"key":"18723_CR2","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1111\/dom.15864","volume":"26","author":"TH Kim","year":"2024","unstructured":"Kim, T. H. et al. Association between glucagon-like peptide-1 receptor agonists and risk of suicidality: A comprehensive analysis of the global pharmacovigilance database. Diabetes Obes. Metab. 26, 5183\u20135191. https:\/\/doi.org\/10.1111\/dom.15864 (2024).","journal-title":"Diabetes Obes. Metab."},{"key":"18723_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/dom.13877","volume":"22","author":"C Bang","year":"2020","unstructured":"Bang, C., Mortensen, M. B., Lauridsen, K. G. & Bruun, J. M. Trends in antidiabetic drug utilization and expenditure in denmark: A 22-year nationwide study. Diabetes Obes. Metab. 22, 167\u2013172. https:\/\/doi.org\/10.1111\/dom.13877 (2020).","journal-title":"Diabetes Obes. Metab."},{"key":"18723_CR4","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s00125-024-06102-x","volume":"67","author":"RIG Holt","year":"2024","unstructured":"Holt, R. I. G., Cockram, C. S., Ma, R. C. W. & Luk, A. O. Y. Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment. Diabetologia 67, 1168\u20131180. https:\/\/doi.org\/10.1007\/s00125-024-06102-x (2024).","journal-title":"Diabetologia"},{"key":"18723_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/dom.13531","volume":"21","author":"CV Dave","year":"2019","unstructured":"Dave, C. V., Schneeweiss, S. & Patorno, E. Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors. Diabetes Obes. Metab. 21, 434\u2013438. https:\/\/doi.org\/10.1111\/dom.13531 (2019).","journal-title":"Diabetes Obes. Metab."},{"issue":"Suppl 2","key":"18723_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2337\/dcS15-3007","volume":"39","author":"A Cahn","year":"2016","unstructured":"Cahn, A. & Cefalu, W. T. Clinical considerations for use of initial combination therapy in type 2 diabetes. Diabetes Care. 39 (Suppl 2), 137\u2013145. https:\/\/doi.org\/10.2337\/dcS15-3007 (2016).","journal-title":"Diabetes Care"},{"key":"18723_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/all.16304","volume":"80","author":"YD Jeong","year":"2025","unstructured":"Jeong, Y. D. et al. Global burden of vaccine-associated angioedema and their related vaccines, 1967\u20132023: findings from the global pharmacovigilance database. Allergy 80, 590\u2013594. https:\/\/doi.org\/10.1111\/all.16304 (2025).","journal-title":"Allergy"},{"key":"18723_CR8","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1007\/s43441-020-00130-6","volume":"54","author":"O Lagerlund","year":"2020","unstructured":"Lagerlund, O., Strese, S., Fladvad, M., Lindquist, M. & WHODrug A global, validated and updated dictionary for medicinal information. Ther. Innov. Regul. Sci. 54, 1116\u20131122. https:\/\/doi.org\/10.1007\/s43441-020-00130-6 (2020).","journal-title":"Ther. Innov. Regul. Sci."},{"key":"18723_CR9","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1038\/s41598-025-88713-x","volume":"15","author":"HS Hwang","year":"2025","unstructured":"Hwang, H. S. et al. Global burden of vaccine-associated kidney injury using an international pharmacovigilance database. Sci. Rep. 15, 5177. https:\/\/doi.org\/10.1038\/s41598-025-88713-x (2025).","journal-title":"Sci. Rep."},{"key":"18723_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jad.2024.12.102","volume":"373","author":"H Cho","year":"2025","unstructured":"Cho, H. et al. Antipsychotic use during pregnancy and outcomes in pregnant individuals and newborns. J. Affect. Disord. 373, 495\u2013504. https:\/\/doi.org\/10.1016\/j.jad.2024.12.102 (2025).","journal-title":"J. Affect. Disord"},{"key":"18723_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s43588-021-00138-4","volume":"1","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Sumathipala, M. & Zitnik, M. Population-scale identification of differential adverse events before and during a pandemic. Nat. Comput. Sci. 1, 666\u2013677. https:\/\/doi.org\/10.1038\/s43588-021-00138-4 (2021).","journal-title":"Nat. Comput. Sci."},{"key":"18723_CR12","doi-asserted-by":"publisher","first-page":"e2423385","DOI":"10.1001\/jamanetworkopen.2024.23385","volume":"7","author":"G Schoretsanitis","year":"2024","unstructured":"Schoretsanitis, G. et al. Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and JAMA Netw. Open. 7, e2423385\u2013e2423385 https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.23385 (2024).","journal-title":"JAMA Netw. Open."},{"key":"18723_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaccao.2022.09.007","volume":"5","author":"S Waliany","year":"2023","unstructured":"Waliany, S. et al. Pharmacovigilance analysis of heart failure associated with Anti-HER2 monotherapies and combination regimens for cancer. JACC CardioOncol. 5, 85\u201398. https:\/\/doi.org\/10.1016\/j.jaccao.2022.09.007 (2023).","journal-title":"JACC CardioOncol"},{"key":"18723_CR14","doi-asserted-by":"publisher","first-page":"105656","DOI":"10.1016\/j.archger.2024.105656","volume":"129","author":"J Kong","year":"2025","unstructured":"Kong, J. et al. Worldwide burden of antidiabetic drug-induced sarcopenia: an international pharmacovigilance study. Arch. Gerontol. Geriatr. 129, 105656. https:\/\/doi.org\/10.1016\/j.archger.2024.105656 (2025).","journal-title":"Arch. Gerontol. Geriatr."},{"key":"18723_CR15","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.54724\/lc.2024.e11","volume":"4","author":"J Cho","year":"2024","unstructured":"Cho, J., Jo, H., Pizzol, D., Smith, L. & Park, J. Global burden of vaccine-associated cutaneous immune-related adverse events, 1968\u20132024: an international pharmacovigilance study. Life Cycle. 4, e11. https:\/\/doi.org\/10.54724\/lc.2024.e11 (2024).","journal-title":"Life Cycle"},{"key":"18723_CR16","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1111\/dom.14124","volume":"22","author":"AK Singh","year":"2020","unstructured":"Singh, A. K. et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Diabetes Obes. Metab. 22, 1915\u20131924. https:\/\/doi.org\/10.1111\/dom.14124 (2020).","journal-title":"Diabetes Obes. Metab."},{"key":"18723_CR17","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1042\/cs20171459","volume":"132","author":"JC Jha","year":"2018","unstructured":"Jha, J. C., Ho, F., Dan, C. & Jandeleit-Dahm, K. A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes. Clin. Sci. (Lond). 132, 1811\u20131836. https:\/\/doi.org\/10.1042\/cs20171459 (2018).","journal-title":"Clin. Sci. (Lond)"},{"key":"18723_CR18","doi-asserted-by":"publisher","unstructured":"Ayelign, B., Negash, M., Genetu, M., Wondmagegn, T. & Shibabaw, T. Immunological impacts of diabetes on the susceptibility of Mycobacterium tuberculosis. J. Immunol. Res. 2019 (6196532). https:\/\/doi.org\/10.1155\/2019\/6196532 (2019).","DOI":"10.1155\/2019\/6196532"},{"key":"18723_CR19","doi-asserted-by":"publisher","unstructured":"Ghezzi, C., Loo, D. D. F. & Wright, E. M. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2. Diabetologia 61, 2087\u20132097 https:\/\/doi.org\/10.1007\/s00125-018-4656-5 (2018).","DOI":"10.1007\/s00125-018-4656-5"},{"key":"18723_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.diabres.2013.12.052","volume":"103","author":"S Geerlings","year":"2014","unstructured":"Geerlings, S., Fonseca, V., Castro-Diaz, D., List, J. & Parikh, S. Genital and urinary tract infections in diabetes: impact of pharmacologically-induced glucosuria. Diabetes Res. Clin. Pract. 103, 373\u2013381. https:\/\/doi.org\/10.1016\/j.diabres.2013.12.052 (2014).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"18723_CR21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.7326\/m19-0085","volume":"170","author":"SJ Bersoff-Matcha","year":"2019","unstructured":"Bersoff-Matcha, S. J., Chamberlain, C., Cao, C., Kortepeter, C. & Chong, W. H. Fournier gangrene associated with Sodium-Glucose Cotransporter-2 inhibitors: A review of spontaneous postmarketing cases. Ann. Intern. Med. 170, 764\u2013769. https:\/\/doi.org\/10.7326\/m19-0085 (2019).","journal-title":"Ann. Intern. Med."},{"key":"18723_CR22","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.jacc.2024.01.040","volume":"83","author":"V Kittipibul","year":"2024","unstructured":"Kittipibul, V. et al. Genitourinary tract infections in patients taking SGLT2 inhibitors: JACC review topic of the week. J. Am. Coll. Cardiol. 83, 1568\u20131578. https:\/\/doi.org\/10.1016\/j.jacc.2024.01.040 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"18723_CR23","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41574-020-0399-8","volume":"16","author":"CF Deacon","year":"2020","unstructured":"Deacon, C. F. Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus. Nat. Rev. Endocrinol. 16, 642\u2013653. https:\/\/doi.org\/10.1038\/s41574-020-0399-8 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"18723_CR24","doi-asserted-by":"publisher","first-page":"e068882","DOI":"10.1136\/bmj-2021-068882","volume":"377","author":"L He","year":"2022","unstructured":"He, L. et al. Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials. Bmj 377, e068882. https:\/\/doi.org\/10.1136\/bmj-2021-068882 (2022).","journal-title":"Bmj"},{"key":"18723_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jinf.2019.09.015","volume":"80","author":"R Dyrhovden","year":"2020","unstructured":"Dyrhovden, R. et al. Bacteria and fungi in acute cholecystitis. A prospective study comparing next generation sequencing to culture. J. Infect. 80, 16\u201323. https:\/\/doi.org\/10.1016\/j.jinf.2019.09.015 (2020).","journal-title":"J. Infect."},{"key":"18723_CR26","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.2337\/dc25-S009","volume":"48","author":"9","year":"2025","unstructured":"9. Pharmacologic approaches to glycemic treatment: standards of care in Diabetes-2025. Diabetes Care. 48, S181\u2013s206. https:\/\/doi.org\/10.2337\/dc25-S009 (2025).","journal-title":"Diabetes Care"},{"key":"18723_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/b978-0-444-53480-4.00014-x","volume":"126","author":"CA Jay","year":"2014","unstructured":"Jay, C. A. & Solbrig, M. V. Neurologic infections in diabetes mellitus. Handb. Clin. Neurol. 126, 175\u2013194. https:\/\/doi.org\/10.1016\/b978-0-444-53480-4.00014-x (2014).","journal-title":"Handb. Clin. Neurol."},{"key":"18723_CR28","doi-asserted-by":"publisher","first-page":"804","DOI":"10.4093\/dmj.2019.0071","volume":"43","author":"EJ Kim","year":"2019","unstructured":"Kim, E. J., Ha, K. H., Kim, D. J. & Choi, Y. H. Diabetes and the risk of infection: A National cohort study. Diabetes Metab. J. 43, 804\u2013814. https:\/\/doi.org\/10.4093\/dmj.2019.0071 (2019).","journal-title":"Diabetes Metab. J."},{"key":"18723_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.therap.2020.02.022","volume":"75","author":"K Bihan","year":"2020","unstructured":"Bihan, K., Lebrun-Vignes, B., Funck-Brentano, C. & Salem, J. E. Uses of pharmacovigilance databases: an overview. Therapie 75, 591\u2013598. https:\/\/doi.org\/10.1016\/j.therap.2020.02.022 (2020).","journal-title":"Therapie"},{"key":"18723_CR30","doi-asserted-by":"publisher","first-page":"1301093","DOI":"10.3389\/fendo.2023.1301093","volume":"14","author":"X Xie","year":"2023","unstructured":"Xie, X. et al. Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review. Front. Endocrinol. (Lausanne). 14, 1301093. https:\/\/doi.org\/10.3389\/fendo.2023.1301093 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"18723_CR31","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s40264-021-01091-x","volume":"44","author":"E Rocca","year":"2021","unstructured":"Rocca, E., Gauffin, O., Savage, R., Vidlin, S. H. & Grundmark, B. Remdesivir in the COVID-19 pandemic: an analysis of spontaneous reports in vigibase during 2020. Drug Saf. 44, 987\u2013998. https:\/\/doi.org\/10.1007\/s40264-021-01091-x (2021).","journal-title":"Drug Saf."},{"key":"18723_CR32","doi-asserted-by":"publisher","first-page":"e245625","DOI":"10.1001\/jamanetworkopen.2024.5625","volume":"7","author":"P Gougis","year":"2024","unstructured":"Gougis, P. et al. Immune checkpoint inhibitor use during pregnancy and outcomes in pregnant individuals and newborns. JAMA Netw. Open. 7, e245625. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.5625 (2024).","journal-title":"JAMA Netw. Open."},{"key":"18723_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40264-020-00911-w","volume":"43","author":"O Caster","year":"2020","unstructured":"Caster, O., Aoki, Y., Gattepaille, L. M. & Grundmark, B. Disproportionality analysis for pharmacovigilance signal detection in small databases or subsets: recommendations for limiting False-Positive associations. Drug Saf. 43, 479\u2013487. https:\/\/doi.org\/10.1007\/s40264-020-00911-w (2020).","journal-title":"Drug Saf."},{"key":"18723_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12916-024-03537-2","volume":"22","author":"H Qu","year":"2024","unstructured":"Qu, H. et al. Differences in hypersensitivity reactions and gadolinium deposition disease\/symptoms associated with gadolinium exposure to gadolinium-based contrast agents: new insights based on global databases vigibase, FAERS, and IQVIA-MIDAS. BMC Med. 22, 329. https:\/\/doi.org\/10.1186\/s12916-024-03537-2 (2024).","journal-title":"BMC Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18723-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18723-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18723-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:41:42Z","timestamp":1759171302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18723-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18723"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18723-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Approval for the use of anonymized and electronically processed individual case data was obtained from the Institutional Review Board of Kyung Hee University. Written informed consent was obtained from all participants and\/or their legal guardians prior to data collection. No other ethical approval is required to conduct this study using secondary data, and the data were not altered or used for any other purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"33583"}}